Mechanistic and Pharmacological Issues of Aspirin as an Anticancer Agent

• Główni autorzy: Paola Patrignani (Autor), Emanuela Ricciotti (Autor), Stefania Tacconelli (Autor), Carlos Sostres (Autor), Melania Dovizio (Autor)
• Format: Książka
• Wydane: MDPI AG, 2012-12-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Recent findings have shown that aspirin, taken for several years, reduces the long-term risk of some cancers, particularly colorectal cancer. The result that aspirin benefit is detectable at daily low-doses (at least 75mg), the same used for the prevention of cardiovascular disease, positions the an...